Text on a pink background: Retina International Welcomes CHMP's Positive Opinion on First Targeted Therapy for Thyroid Eye DIsease. The Retina International logo is centered at the bottom of the graphic.

Text on a pink background: This is a pivotal moment for the TED community. Avril Daly, CEO, Retina International. The Retina International logo is centered at the bottom of the graphic.

We warmly welcome the @ema.europa.eu CHMP’s positive opinion on the first targeted therapy for Thyroid Eye Disease (TED).

🔗 Read more: retina-international.org/ted-press-re...

#RareDisease #TED #RetinaInternational #VisionHealth #InnovationInSight @amgen.bsky.social @avrilbdaly.bsky.social

Graphic for World Health Day, April 7, 2025. The background is dark slate grey with a stylized gold outline of an eye in the center. Above the eye, large white text reads: "World Health Day," and below it, smaller text reads: "April 7, 2025." Under the eye is the hashtag "#HealthForAll." At the bottom are the logos of the World Health Organization (WHO) on the left and Retina International on the right. A soft green curve enters the image from the lower right corner.

Today, on @who.int #WorldHealthDay, we’re highlighting inherited retinal diseases in maternal and newborn care. Early diagnosis = healthier futures. #HealthForAll #GeneticTesting #WHO #RetinaInternational #EyeHealth #VisionResearch #Ophthalmology #ScienceResearch #WorldHealthDay

Retina International Perspectives Podcast Podcast · Retina International · Each month, we feature powerful personal stories from our members, offering a unique window into their experiences, challenges, and triumphs. In addition to these firs...

The Retina International Perspectives #Podcast is now on Spotify! Retina International shares expert insights, personal stories, and the latest research in inherited retinal diseases. Tune in and subscribe:

🎧 Listen here: open.spotify.com/show/39wshES...

#RetinaInternational #IRDCommunity

🛑 The cost of inaction? €250B+ annually.
✅ The solution? Faster diagnosis, better access, & holistic care. #RareDisease #RareDiseases #HealthEquity #PatientAdvocacy #RetinaInternational

A virtual meeting screenshot from Retina International's Education Hub. The title slide reads, “Regulation and regulatory bodies: what is involved and how can patients make a difference.” Various speakers, including Avril Daly, Joan O’Callaghan, and Russell Wheeler, are visible in the session.

A screenshot from the Education Hub event. The slide from the European Medicines Agency (EMA) titled “Who we are” is displayed, explaining different committees. Participants, including Kaisa Immonen and Dr. Jane Moseley, are highlighted in the Zoom call.

A mix of presentation slides and speaker views. One slide from the NCPE outlines the HTA (Health Technology Assessment) process, showing the connection between NCPE, HTA, and payers. The session features discussions on patient involvement in regulatory decisions.

Another fantastic #EducationHub session: We discussed the role of patients in research & regulation, with expert insights from NCPE & @ema.europa.eu. Patients are not just participants - they’re decision-makers.

More: shorturl.at/QK1mG

#RetinaInternational #PatientAdvocacy #HTA #RegulatoryAffairs